SAMANTHA HARMS: Open Payments
NPI 1902248115 · BLUE SPRINGS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 64 payments from 25 companies in 2025. Trend: 2023 $1,188 · 2024 $1,486 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $284 |
| AstraZeneca Pharmaceuticals LP | 8 | $265 |
| Lilly USA, LLC | 6 | $103 |
| ABBVIE INC. | 4 | $78 |
| PFIZER INC. | 4 | $68 |
| Radius Health, Inc. | 2 | $63 |
| Antares Pharma, Inc. | 3 | $54 |
| Ardelyx, Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $51 |
| GlaxoSmithKline, LLC. | 3 | $50 |
Products named: Ozempic, FARXIGA, AIRSUPRA, MOUNJARO, Tymlos, VRAYLAR, XYOSTED, Rybelsus.
Industry payments across MO — which companies pay providers there.
